Baker Brothers Advisors - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 154 filers reported holding REATA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$8,508,848
+51.2%
223,9760.0%0.05%
+37.8%
Q3 2022$5,629,000
-17.3%
223,9760.0%0.04%
-5.1%
Q2 2022$6,807,000
-7.2%
223,9760.0%0.04%
-7.1%
Q1 2022$7,337,000
+24.2%
223,9760.0%0.04%
+44.8%
Q4 2021$5,906,000
-73.8%
223,9760.0%0.03%
-70.7%
Q3 2021$22,534,000
-28.9%
223,9760.0%0.10%
-28.8%
Q2 2021$31,699,000
+42.0%
223,9760.0%0.14%
+43.3%
Q1 2021$22,330,000
-19.4%
223,9760.0%0.10%
-6.7%
Q4 2020$27,688,000
+434.4%
223,976
+321.1%
0.10%
+395.2%
Q3 2020$5,181,000
-40.7%
53,183
-5.0%
0.02%
-46.2%
Q2 2020$8,734,000
+8.1%
55,9830.0%0.04%
-22.0%
Q1 2020$8,081,000
-3.5%
55,983
+36.6%
0.05%
+11.1%
Q4 2019$8,378,00040,9830.04%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders